GlassScriptPhysician profile
Eyson P Concepcion
NPI 1457758906
$3,492.25
in general payments reported to CMS, 2019-2025
31 companies · $1,067 in 2025
The $1,067 reported for 2025 was more than what 86% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $299 · 2022: $684 · 2023: $886 · 2024: $556 · 2025: $1,067.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,508.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $621.97 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $515.93 | 2021-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $317.15 | 2023-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $294.41 | 2021-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $258.11 | 2022-2025 | Verquvo |
| Alnylam Pharmaceuticals INC. | $222.22 | 2023-2025 | Amvuttra |
| Regeneron Healthcare Solutions, INC. | $217.39 | 2021-2025 | Evkeeza, Praluent |
| Edwards Lifesciences Corporation | $211.03 | 2022 | |
| Abbvie INC. | $98.28 | 2023-2024 | |
| Irhythm Technologies, INC. | $68.65 | 2024 | Zio Monitor, Zio Xt Patch |
| Amgen INC. | $53.72 | 2022-2023 | Evenity, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $52.15 | 2023-2025 | |
| Caris Mpi, INC. | $48.71 | 2025 | Mi Cancer Seek |
| Kiniksa Pharmaceuticals, LTD. | $46.18 | 2022-2023 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $45.47 | 2023-2024 | Inpefa |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $44.80 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $44.26 | 2023-2024 | Wainua |
| Ionis Pharmaceuticals, INC. | $36.19 | 2025 | Tryngolza |
| Shockwave Medical, INC | $34.24 | 2025 | |
| Inspire Medical Systems, INC. | $32.50 | 2025 | Inspire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $31.82 | 2021-2023 | Lifevest |
| Daiichi Sankyo INC. | $29.31 | 2023 | Injectafer |
| Kiniksa Pharmaceuticals International, Plc | $24.96 | 2024 | Arcalyst |
| Recor Medical INC | $20.76 | 2024 | Paradise Renal Denervation System |
| Amarin Pharma, INC. | $18.25 | 2021 | |
| Novo Nordisk INC | $17.99 | 2021 | |
| Idorsia Pharmaceuticals US INC | $17.87 | 2025 | Tryvio |
| Teleflex LLC | $17.79 | 2025 | Guideliner |
| Scpharmaceuticals INC. | $17.54 | 2023 | |
| Boston Scientific Corporation | $17.08 | 2024 | |
| Baxter Healthcare | $15.52 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eyson Concepcion listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.